Efficacy and effectiveness of an rVSV-vectored #vaccine in preventing #Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32621-6/fulltext

The results add weight to the interim assessment that rVSV-ZEBOV offers substantial protection against Ebola virus disease, with no cases among vaccinated individuals from day 10 after vaccination in both randomised and non-randomised clusters.